针对淋巴结的疫苗增强TCRT细胞疗法增强抗瘤功能,消除固体瘤
Dylan J Drakes1, Abdulraouf M Abbas1, Jacqueline Shields1
1Elicio Therapeutics, Boston, Massachusetts.
Cancer immunology research
|January 25, 2024
概括
双胞胎 (AMP) 疫苗接种增强T细胞受体 (TCR) 固体瘤的T细胞治疗. 这种组合增强T细胞的持久性和功能,导致瘤彻底根除和在临床前模型中持久的反应.
科学领域:
- 免疫学 免疫学 免疫学
- 在瘤学瘤学.
- 生物技术是生物技术.
背景情况:
- 经T细胞受体 (TCR) 修饰的T细胞疗法对固体瘤有前途,但在T细胞持久性,激活和抗原逃逸方面面临挑战.
- 目前的TCR T细胞疗法在体内往往产生适度的治疗效益.
研究的目的:
- 为了增强TCR T细胞的体内持久性和功能,使用两 (AMP) 疫苗接种.
- 为了评估AMP疫苗接种与TCRT细胞治疗对已确定的固体瘤的组合.
主要方法:
- 使用AMP疫苗接种,结合相关的TCRT细胞,以免疫原和辅助剂向淋巴结.
- 组合治疗的有效性在小鼠实体瘤模型中进行了评估.
- 在体外研究中,评估了AMP类与向特定瘤抗原 (NY-ESO-1,KRAS,HPV16 E7) 的人类TCR T细胞.
主要成果:
- 与TCR-T细胞疗法的AMP疫苗组合实现了对TCR-T细胞单一疗法耐药的固体瘤的完全根除和持久反应.
- 增强的抗瘤疗效与转移的TCR T细胞的改善体内持久性和内源性T细胞的扩张相关.
- AMP疫苗接种促进了淋巴结重编程,抗原呈现细胞成熟和T细胞扩张,而没有淋巴缺失.
- 实验室研究表明,AMP有可能增强人类TCRT细胞的增殖,激活和抗瘤活性.
结论:
- AMP疫苗接种是一种有前途的策略,可以刺激TCRT细胞并增加抗瘤活性.
- 将AMP疫苗接种与TCRT细胞疗法相结合,提供了一种潜在的方法,以克服目前对固体瘤的T细胞疗法的局限性.
- 这些发现支持进一步临床评估AMP疫苗接种与TCRT细胞疗法结合.
相关概念视频
01:27Tumor Immunotherapy
526
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
526
02:57Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K
01:30Cancer Vaccines
367
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
367
01:27Cytotoxic T Cells-mediated Immune Response
917
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
917